Recent Insights into the Management of Pleural Infection

Abstract

Maged Hassan,1 Shefaly Patel,2 Ahmed S Sadaka,1 Eihab O Bedawi,2 John P Corcoran,3 José M Porcel4 1Chest Diseases Department, Alexandria University Faculty of Medicine, Alexandria, Egypt; 2Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK; 3Department of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK; 4Department of Internal Medicine, Arnau de Vilanova University Hospital, Lleida, SpainCorrespondence: Maged HassanChest Diseases Department, Alexandria University Faculty of Medicine, Alexandria, EgyptTel [phone]Email [email protected]: Pleural infection in adults has considerable morbidity and continues to be a life-threatening condition. The term “pleural infection” encompasses complicated parapneumonic effusions and primary pleural infections, and includes but is not limited to empyema, which refers to collection of pus in the pleural cavity. The incidence of pleural infection in adults has been continuously increasing over the past two decades, particularly in older adults, and most of such patients have comorbidities. Management of pleural infection requires prolonged duration of hospitalization (average 14 days). There are recognized differences in microbial etiology of pleural infection depending on whether the infection was acquired in the community or in a health-care setting. Anaerobic bacteria are acknowledged as a major cause of pleural infection, and thus anaerobic coverage in antibiotic regimens for pleural infection is mandatory. The key components of managing pleural infection are appropriate antimicrobial therapy and chest-tube drainage. In patients who fail medical therapy by manifesting persistent sepsis despite standard measures, surgical intervention to clear the infected space or intrapleural fibrinolytic therapy (in poor surgical candidates) are recommended. Recent studies have explored the role of early intrapleural fibrinolytics or first-line surgery, but due to considerable costs of such interventions and the lack of convincing evidence of improved outcomes with early use, early intervention cannot be recommended, and further evidence is awaited from ongoing studies. Other areas of research include the role of routine molecular testing of infected pleural fluid in improving the rate of identification of causative organisms. Other research topics include the benefit of such interventions as medical thoracoscopy, high-volume pleural irrigation with saline/antiseptic solution, and repeated thoracentesis (as opposed to chest-tube drainage) in reducing morbidity and improving outcomes of pleural infection. This review summarizes current knowledge and practice in managing pleural infection and future research directions.Keywords: pleural infection, empyema, respiratory infections, pneumonia

Keywords

• pleural infection
• empyema
• respiratory infections
• pneumonia